Jensen Investment Management Inc. Sells 10,480 Shares of Encompass Health Co. (NYSE:EHC)

Jensen Investment Management Inc. trimmed its position in shares of Encompass Health Co. (NYSE:EHC - Free Report) by 11.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 81,730 shares of the company's stock after selling 10,480 shares during the quarter. Jensen Investment Management Inc. owned approximately 0.08% of Encompass Health worth $7,548,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Envestnet Portfolio Solutions Inc. grew its stake in shares of Encompass Health by 8.2% in the fourth quarter. Envestnet Portfolio Solutions Inc. now owns 9,488 shares of the company's stock worth $876,000 after purchasing an additional 716 shares during the last quarter. CBIZ Investment Advisory Services LLC lifted its holdings in Encompass Health by 38.7% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock worth $42,000 after buying an additional 127 shares during the period. one8zero8 LLC bought a new stake in shares of Encompass Health in the 4th quarter valued at about $394,000. Globeflex Capital L P increased its stake in shares of Encompass Health by 305.5% in the fourth quarter. Globeflex Capital L P now owns 42,739 shares of the company's stock valued at $3,947,000 after buying an additional 32,200 shares during the period. Finally, Madison Investment Advisors LLC bought a new position in shares of Encompass Health during the fourth quarter worth about $8,118,000. 97.25% of the stock is currently owned by institutional investors.

Encompass Health Stock Down 0.2 %

Encompass Health stock traded down $0.23 during midday trading on Thursday, reaching $99.13. The stock had a trading volume of 565,615 shares, compared to its average volume of 631,575. The company has a fifty day moving average price of $97.73 and a two-hundred day moving average price of $97.06. The company has a market capitalization of $9.98 billion, a P/E ratio of 22.23, a PEG ratio of 2.31 and a beta of 0.92. The company has a current ratio of 1.05, a quick ratio of 1.04 and a debt-to-equity ratio of 0.84. Encompass Health Co. has a 12 month low of $76.11 and a 12 month high of $104.55.

Remove Ads

Encompass Health (NYSE:EHC - Get Free Report) last issued its earnings results on Thursday, February 6th. The company reported $1.17 earnings per share for the quarter, topping analysts' consensus estimates of $1.05 by $0.12. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. As a group, equities analysts expect that Encompass Health Co. will post 4.8 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be given a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a dividend yield of 0.69%. The ex-dividend date is Tuesday, April 1st. Encompass Health's payout ratio is presently 15.25%.

Insider Buying and Selling

In related news, CAO Andrew L. Price sold 5,042 shares of Encompass Health stock in a transaction that occurred on Thursday, February 13th. The stock was sold at an average price of $98.29, for a total transaction of $495,578.18. Following the transaction, the chief accounting officer now owns 69,164 shares of the company's stock, valued at $6,798,129.56. The trade was a 6.79 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 2.10% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several brokerages recently commented on EHC. StockNews.com upgraded Encompass Health from a "hold" rating to a "buy" rating in a report on Saturday, February 15th. Barclays increased their price objective on shares of Encompass Health from $116.00 to $118.00 and gave the stock an "overweight" rating in a research report on Friday, February 7th. William Blair restated an "outperform" rating on shares of Encompass Health in a report on Friday, February 7th. KeyCorp increased their price target on Encompass Health from $117.00 to $120.00 and gave the stock an "overweight" rating in a report on Monday, February 10th. Finally, Royal Bank of Canada reissued an "outperform" rating and issued a $110.00 price objective on shares of Encompass Health in a research report on Tuesday, February 11th. Ten analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Buy" and a consensus target price of $107.67.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.